40 mg laninamivir octanoate

DRUG2 trials

Sponsors

Biota Scientific Management Pty Ltd

Conditions

Influenza

Phase 1

Safety & Pharmacokinetics Study of Inhaled Laninamivir Octanoate TwinCaps® Dry Powder Inhaler in Children With Influenza

TerminatedNCT02014649

Biota Scientific Management Pty LtdInfluenza

Start: 2013-11-30End: 2014-05-31Updated: 2025-01-13

Phase 2

Efficacy and Safety Study of Laninamivir Octanoate TwinCaps® Dry Powder Inhaler in Adults With Influenza

CompletedNCT01793883

Biota Scientific Management Pty LtdInfluenza

Start: 2013-05-31End: 2014-05-31Updated: 2018-05-31